Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

NCT02678572 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma, Ocular

Interventions

COMBINATION_PRODUCT: Melphalan/HDS

Sponsor

Delcath Systems Inc.

Collaborators

[object Object]